# Pegylated Interferon Lambda for Treatment of COVID-19 Infection

> **NCT04534673** · PHASE2 · COMPLETED · sponsor: **Soroka University Medical Center** · enrollment: 9 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Lambda 180 mcg S.C

## Key facts

- **NCT ID:** NCT04534673
- **Lead sponsor:** Soroka University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-07
- **Primary completion:** 2023-02-16
- **Final completion:** 2023-02-16
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04534673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04534673, "Pegylated Interferon Lambda for Treatment of COVID-19 Infection". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT04534673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*